May 17, 2018 / 11:01 PM / 9 days ago

BRIEF-U.S. FDA Approved Aimovig For Preventive Treatment Of Migraine In Adult

May 17 (Reuters) -

* U.S. FDA APPROVES NOVEL PREVENTIVE TREATMENT FOR MIGRAINE

* U.S. FDA SAYS IT GRANTED THE APPROVAL OF AIMOVIG TO AMGEN INC

* U.S. FDA APPROVED AIMOVIG (ERENUMAB-AOOE) FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULT Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below